Wu Yang-Chang, Hsu Jen-Hao, Liu I-Min, Liou Shorong-Shii, Su Hui-Chen, Cheng Juei-Tang
Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung City, Taiwan, China.
Acta Pharmacol Sin. 2002 Dec;23(12):1181-7.
Effects on insulin sensitivity of die-huang-wan, the herbal mixture widely used to treat diabetic disorder in Chinese traditional medicine, were investigated in vivo.
The obese Zucker rats were employed as insulin-resistant animal model. Also, insulin-resistance was induced by the repeated intraperitoneal injections of long-acting human insulin at 0.5 U/kg three times daily into adult male Wistar rats. Insulin resistance was identified using the loss of tolbutamide (10 mg/kg) or electroacupuncture (EA)-induced plasma glucose lowering action. The plasma glucose concentration was examined by glucose oxidase assay.
The plasma glucose-lowering action induced by tolbutamide was significantly enhanced in obese Zucker rats receiving the repeated administration of die-huang-wan at dosage of 26 mg/kg for 3 d. Furthermore, administration of die-huang-wan delayed the formation of insulin resistance in rats that were induced by the daily repeated injection of human long-acting insulin at 0.5 U/kg three times daily and identified by the loss of tolbutamide- or EA-induced hypoglycemia. In streptozotocin-induced diabetic rats, oral administration of metformin at 320 mg/kg once daily made an increase of the response to exogenous short-acting human insulin 15 d later. This is consistent with the view that metformin can increase insulin sensitivity. Similar treatment with die-huang-wan at an effective dose (26.0 mg/kg) also increased the plasma glucose lowering action of exogenous insulin at 10 d later. The effect of die-huang-wan on insulin sensitivity seems to produce more rapidly than that of metformin.
The present study found that oral administration of die-huang-wan increased insulin sensitivity and delayed the development of insulin resistance in rats.
在体内研究中药中广泛用于治疗糖尿病病症的中药复方地黄丸对胰岛素敏感性的影响。
将肥胖Zucker大鼠用作胰岛素抵抗动物模型。此外,通过每日三次以0.5 U/kg的剂量对成年雄性Wistar大鼠进行长效人胰岛素的重复腹腔注射来诱导胰岛素抵抗。使用甲苯磺丁脲(10 mg/kg)作用丧失或电针(EA)诱导的血浆葡萄糖降低作用来鉴定胰岛素抵抗。通过葡萄糖氧化酶测定法检测血浆葡萄糖浓度。
在以26 mg/kg的剂量重复给予地黄丸3天的肥胖Zucker大鼠中,甲苯磺丁脲诱导的血浆葡萄糖降低作用显著增强。此外,给予地黄丸可延缓每日三次以0.5 U/kg的剂量重复注射人长效胰岛素诱导的大鼠胰岛素抵抗的形成,并通过甲苯磺丁脲或EA诱导的低血糖作用丧失来鉴定。在链脲佐菌素诱导的糖尿病大鼠中,每日一次口服320 mg/kg的二甲双胍15天后对外源短效人胰岛素的反应增加。这与二甲双胍可增加胰岛素敏感性的观点一致。以有效剂量(26.0 mg/kg)的地黄丸进行类似治疗10天后也增加了外源胰岛素的血浆葡萄糖降低作用。地黄丸对胰岛素敏感性的作用似乎比二甲双胍产生得更快。
本研究发现口服地黄丸可增加大鼠的胰岛素敏感性并延缓胰岛素抵抗的发展。